Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol (Q45034136)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol
scientific article

    Statements

    title
    Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    15333491
    retrieved
    8 December 2017
    author name string
    Jiri Frohlich
    series ordinal
    2
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    15333491
    retrieved
    8 December 2017
    Marianne Harris
    series ordinal
    4
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    15333491
    retrieved
    8 December 2017
    Tom Elliott
    series ordinal
    5
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    15333491
    retrieved
    8 December 2017
    publication date
    1 September 2004
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    15333491
    retrieved
    8 December 2017
    page(s)
    2241-2242
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    15333491
    retrieved
    8 December 2017

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q45034136&oldid=2117478789"